Cliff Asness's AVXL Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 756,792 shares of Anavex Life Sciences Corp. (AVXL) worth $2.32 M, representing 0.00% of the portfolio. First purchased in 2020-Q1, this long-term strategic position has been held for 25 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in AVXL, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2026, adding 606,977 shares. Largest reduction occurred in Q4 2024, reducing 88,329 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Anavex Life Sciences (AVXL) Holding Value Over Time
Track share changes against reported price movement
Quarterly Anavex Life Sciences (AVXL) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +606,977 | Add 405.15% | 756,792 | $3.07 |
| Q4 2025 | +121,779 | Add 434.37% | 149,815 | $3.56 |
| Q3 2025 | -1,027 | Reduce 3.53% | 28,036 | $8.90 |
| Q2 2025 | -78 | Reduce 0.27% | 29,063 | $9.22 |
| Q1 2025 | -19,174 | Reduce 39.69% | 29,141 | $8.58 |
| Q4 2024 | -88,329 | Reduce 64.64% | 48,315 | $10.74 |
| Q3 2024 | +91,425 | Add 202.18% | 136,644 | $5.68 |
| Q2 2024 | +26,821 | Add 145.78% | 45,219 | $4.22 |
| Q1 2024 | -203 | Reduce 1.09% | 18,398 | $5.09 |
| Q4 2023 | +1,809 | Add 10.77% | 18,601 | $9.31 |
| Q3 2023 | +3,459 | Add 25.94% | 16,792 | $6.55 |
| Q2 2023 | +892 | Add 7.17% | 13,333 | $8.13 |
| Q1 2023 | -12,937 | Reduce 50.98% | 12,441 | $8.57 |
| Q4 2022 | -393 | Reduce 1.52% | 25,378 | $9.26 |
| Q3 2022 | +1,469 | Add 6.04% | 25,771 | $10.32 |
| Q2 2022 | -4,117 | Reduce 14.49% | 24,302 | $10.00 |
| Q1 2022 | -8,061 | Reduce 22.10% | 28,419 | $12.32 |
| Q4 2021 | +5,854 | Add 19.11% | 36,480 | $17.35 |
| Q3 2021 | +1,431 | Add 4.90% | 30,626 | $17.96 |
| Q2 2021 | +776 | Add 2.73% | 29,195 | $22.85 |
| Q1 2021 | -11,213 | Reduce 28.29% | 28,419 | $14.95 |
| Q4 2020 | +1,694 | Add 4.47% | 39,632 | $5.40 |
| Q3 2020 | +1,923 | Add 5.34% | 37,938 | $4.56 |
| Q2 2020 | +15,456 | Add 75.18% | 36,015 | $4.91 |
| Q1 2020 | +20,559 | New Buy | 20,559 | $3.16 |
Cliff Asness's Anavex Life Sciences Investment FAQs
Cliff Asness first purchased Anavex Life Sciences Corp. (AVXL) in Q1 2020, acquiring 20,559 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Anavex Life Sciences Corp. (AVXL) for 25 quarters since Q1 2020.
Cliff Asness's largest addition to Anavex Life Sciences Corp. (AVXL) was in Q1 2026, adding 756,792 shares worth $2.32 M.
According to the latest 13F filing for Q1 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 756,792 shares of Anavex Life Sciences Corp. (AVXL), valued at approximately $2.32 M.
As of the Q1 2026 filing, Anavex Life Sciences Corp. (AVXL) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Anavex Life Sciences Corp. (AVXL) was 756,792 shares, as reported at the end of Q1 2026.